Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation

By Jung C.   Engelmann E.   Borner K.   Offermann G.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3621-3623

Elsevier

Access to resources Recommend Favorite

Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days' intravenous ganciclovir

By Paniagua M.J.   Crespo-Leiro M.G.   De la Fuente L.   Tabuyo T.   Mosquera I.   Canizares A.   Naya C.   Farina P.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 69-70

Elsevier

Access to resources Recommend Favorite

Serum elastase and antithrombin-3 levels after umbilical cord blood transplantation or bone marrow transplantation

By Toda Akinari   Takatsuka Hiroyuki   Nakajima Toshiyuki   Nomura Kaori   Wakae Takeshi   Itoi Hisayuki   Okada Masaya   Misawa Mahito   Hara Hiroshi  

Hematology, Vol. 12, Iss. 1, 2007-02 ,pp. : 29-31

Maney Publishing

Access to resources Recommend Favorite

Detection of cytomegalovirus proteins by flow cytometry in the blood of patients undergoing hematopoietic stem cell transplantation - a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow t

By Detrick B.   Hooks J.J.   Keiser J.   Tabbara I.  

Experimental Hematology, Vol. 27, Iss. 3, 1999-03 ,pp. : 569-575

Elsevier

Access to resources Recommend Favorite

Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients

By Paniagua M.J.   Crespo-Leiro M.G.   Rodriguez J.A.   Fojon S.   Zuniga M.C.   Canizares A.   Rey R.   Cuenca J.J.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2528-2529

Elsevier

Access to resources Recommend Favorite